Chalevelakis G, Yalouris A G, Lyberatos C, Economopoulos T, Anastasiou C, Hatziioannou J, Raptis S
Second Department of Internal Medicine, University of Athens, Evangelismos Hospital, Greece.
J Clin Pathol. 1989 Sep;42(9):977-81. doi: 10.1136/jcp.42.9.977.
The effect of isonicotinic acid hydrazide (INH), a potent haem inhibitor, on globin chain synthesis was studied in reticulocytes from the following groups of patients: four non-thalassaemic patients (group i); five beta thalassaemia heterozygotes (group ii); three Hb S/beta thalassaemia heterozygotes (group iii); and two additional patients--one with homozygous beta thalassaemia and the other with thalassaemia intermedia (group iv). This was done to determine whether haem inhibitors depress alpha globin chain synthesis. The progressive increase of INH concentration (10-40 mmol l-1) in reticulocytes from a beta thalassaemia heterozygote resulted in a remarkable decrease of the alpha and beta chain synthesis, ranging from 80% to 97% and from 74% to 96% of control values, respectively, and in a gradual drop of alpha:beta ratio from 1.87 to 1.38. Furthermore, in the samples incubated with 40 mmol l-1 INH, a pronounced inhibition of globin chain synthesis 77 (19%) for alpha chain and 67 (27%) for beta or beta S chain) and a substantial drop of the alpha:beta or beta S ratio in samples with INH (median 1.16) compared with that in samples without INH (median 1.70) were observed. The inhibitory effect of INH was significantly or completely corrected by adding exogenous haem. It is suggested that haem inhibition and the resulting preferential diminution of alpha chain synthesis could provide a new approach to the treatment of homozygous beta thalassaemia with an excess of detrimental free alpha chain in erythroid cells.
研究了强力血红素抑制剂异烟肼(INH)对以下几组患者网织红细胞中珠蛋白链合成的影响:4名非地中海贫血患者(第一组);5名β地中海贫血杂合子(第二组);3名Hb S/β地中海贫血杂合子(第三组);以及另外两名患者——一名纯合子β地中海贫血患者和另一名中间型地中海贫血患者(第四组)。这样做是为了确定血红素抑制剂是否会抑制α珠蛋白链的合成。β地中海贫血杂合子网织红细胞中INH浓度(10 - 40 mmol l-1)的逐步增加导致α链和β链合成显著减少,分别为对照值的80%至97%和74%至96%,α:β比值从1.87逐渐降至1.38。此外,在与40 mmol l-1 INH孵育的样本中,观察到珠蛋白链合成受到明显抑制(α链为77(19%),β或βS链为67(27%)),并且与未添加INH的样本(中位数1.70)相比,添加INH的样本中α:β或βS比值大幅下降(中位数1.16)。添加外源性血红素可显著或完全纠正INH的抑制作用。有人提出,血红素抑制以及由此导致的α链合成优先减少,可能为治疗红细胞中有害游离α链过量的纯合子β地中海贫血提供一种新方法。